The largest database of trusted experimental protocols

11 protocols using ms2 p65 hsf1

1

Lentiviral Transduction of Human Fibroblasts

Check if the same lab product or an alternative is used in the 5 most similar protocols
Briefly, 5 × 105 HFFs were seeded in T75 flask, cultured in growth medium without antibiotics for 24 h, and then transduced with lentiviral supernatant containing dCas9-VP64 (a gift from Feng Zhang, Addgene #61425) and MS2-P65-HSF1 (a gift from Feng Zhang, Addgene #61426) at a final concentration of 8 μg/mL polybrene. Twenty-four hours after transduction, lentiviral supernatant was replaced by selection medium. The working concentration of selection reagent was determined by a kill curve: 1 μg/mL blasticidin S HCL and 15 μg/mL hygromycin B. Medium was refreshed every 3 days and cells were passaged on day 7. HFFs without virus infection served as a negative control. pLenti CMV GFP Blast (a gift from Eric Campeau & Paul Kaufman, Addgene #17445) transduction control indicated transduction efficiency.
+ Open protocol
+ Expand
2

Stable Cell Lines with Overexpressed AhR

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lentiviral infections were used to obtain stable cell lines. Lentiviral production was performed as recommended (http://tronolab.epfl.ch) using HEK 293T cells, psPAX2 (Addgene, Cambridge, MA, USA #12260) and pVSV‐G (Addgene, #14888) plasmids, and the required vectors. Infections were performed overnight. To generate 501Mel cells individually overexpressing AhR, 501Mel cells were first transduced to stably express dCAS‐VP64 (Addgene, #61425) and MS2‐P65‐HSF1 (Addgene, #61426) before transduction with specific AhR sgRNAs (from Supplementary Table S of Gautron et al, 2021 (link)). Infected cells were selected using zeocin (600 μg/ml, 5 days). Lentivirus was manipulated in the biosafety level 3 containment laboratory core facility of the Biology and Health Federative Research Structure of Rennes (Biosit).
+ Open protocol
+ Expand
3

Activating Gene Expression with dCas9

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasmids carrying dCas9-VP64 and MS2-p65-HSF1 were purchased from Addgene (Watertown, MA, USA). pMSCV-LTR-dCas9-VP64-BFP was a gift from Stanley Qi and Jonathan Weissman (Addgene plasmid #46912). Lenti MS2-p65-HSF1_Hygro was a gift from Feng Zhang (Addgene plasmid #61426). The gRNA scaffold plasmid was synthesized based on previous efforts [16 (link)]. The genes of interest were isolated and integrated into the mammalian expression vector pcDNA3.1 by Gibson Assembly using HiFi DNA Assembly Master Mix from NewEngland BioLabs (Ipswich, MA, USA) per the manufacturer’s instructions. Bacteriophage MS2 (MS2), Bacteriophage Q-beta (Qb), Pseudomonas Phage PP7 (PP7), Enterobacteria Phage Lambda (Lambda), Satellite Tobacco Necrosis Virus (STNV), and Bovine Immunodeficiency Virus Trans-Activation Response (BIV-TAR) stem loop and aptamer DNA sequences were synthesized by IDT (Coralville, IA, USA) and assembled into a gRNA backbone in a pcDNA3.1 expression in a similar fashion.
+ Open protocol
+ Expand
4

Lentivirus Production and Cell Selection

Check if the same lab product or an alternative is used in the 5 most similar protocols
The lentiviruses were produced in HEK-293FT cells using plasmids sgRNA (MS2) (#61427; Addgene, Cambridge, MA, USA), dCas9-VP64 (#61425; Addgene, Cambridge, MA, USA), or MS2-P65-HSF1 (#61426; Addgene, Cambridge, MA, USA). The sgRNA sramble (SCR) was constructed with the sequence GCACTACCAGAGCTAACTCA and the sgRNA T2 with the sequence ACATTACAAGTTGCAAATCA, according to protocol established by Konermann et al. (30 (link)).
Transduction and cell selection were performed serially: dCas9-VP64 was selected with blasticidin; MS2-P65-HSF1 was selected with hygromycin; and sgRNA-SCR or sgRNA-T2 was selected with zeocin. The concentration of antibiotics used was determined through a dose–response curve. The cells were plated to reach 50% of confluency 48 h before transduction and maintained for 24 h with a solution (1:1) of viral supernatant in culture medium, followed by of antibiotic selection until control cells died.
+ Open protocol
+ Expand
5

Genome-Scale CRISPR Screen for Vemurafenib Resistance

Check if the same lab product or an alternative is used in the 5 most similar protocols
The vemurafenib resistance screen was conducted similarly to a
previously described genome-scale SAM coding gene screen 12 (link). A375 stably integrated with dCas9-VP64
(Addgene 61425) and MS2-P65-HSF1 (Addgene 61426) were transduced with the pooled
sgRNA library (Addgene 61427) as described above at an MOI of 0.3 for a total of
4 infection replicates, with a minimal representation of 500 transduced cells
per sgRNA in each replicate. Cells were maintained at >500 cells per
sgRNA during subsequent passaging. After 7 days of Zeocin selection and 2 days
of no antibiotic selection, cells were split into control (DMSO) and vemurafenib
(2 μM PLX-4720 dissolved in DMSO, Selleckchem S1152) conditions. Cells
were passaged every 2 days for a total of 14 days of control or vemurafenib
treatment. The 14-day screening duration was selected based on previous studies
12 (link),23 (link),26 (link). At the end of the screening selection, >500 cells
per sgRNA in each condition were harvested for gDNA extraction and amplification
of the virally integrated sgRNAs as described previously 27 (link). Resulting libraries were deep-sequenced
on Illumina MiSeq or NextSeq platforms with a coverage of >25 million
reads passing filter per library.
+ Open protocol
+ Expand
6

RNA-seq of CRISPR-Cas9 edited HEK293FT

Check if the same lab product or an alternative is used in the 5 most similar protocols
HEK293FT cells were co-transfected with 10 ng gRNA targeting MIAT locus, 200 ng Cas9 constructs, 100 ng MS2-P65-HSF1 (Addgene plasmid ID: 61423), and 25 ng transfection control. Total RNA was extracted 72 h post transfection using RNeasy Plus mini kit (Qiagen) and sent to UCLA TCGB core on dry ice. Ribosomal RNA depletion, and single read library preparation were performed at UCLA core followed by RNA sequencing using NextSeq500. Coverage was 14 million reads per sample. FASTQ files with single-ended 75 bp reads were then aligned to the human GRCh38 reference genome sequence (Ensembl release 90) with STAR54 (link), and uniquely-mapped read counts (an average of 14.8 million reads per sample) were obtained with Cufflink55 (link). The read counts for each sample were then normalized for the library size to CPM (counts per million reads) with edgeR56 (link). Custom R scripts were then used to generate plots.
+ Open protocol
+ Expand
7

CRISPR-Cas9 Transfection and qRT-PCR

Check if the same lab product or an alternative is used in the 5 most similar protocols
HEK293FT cells were co-transfected with 10 ng gRNA, 200 ng Cas9 constructs, 100 ng MS2-P65-HSF1 (Addgene plasmid ID: 61423) and 25 ng EBFP plasmid as the transfection control. Cells were lysed, and RNA was extracted using RNeasy Plus mini kit (Qiagen) 72 h post transfection, followed by cDNA synthesis using the High-Capacity RNA-to-cDNA Kit (Thermo Fisher). qRT-PCR was performed using SYBR Green PCR Master Mix (Thermo Fisher). All analyses were normalized to 18S rRNA (ΔCt) and fold changes were calculated against untransfected controls (2−ΔΔCt). Primer sequences for qPCR are listed in Supplementary Table 7.
+ Open protocol
+ Expand
8

Endogenous Nrf1 Activation via CRISPR-dCAS9

Check if the same lab product or an alternative is used in the 5 most similar protocols
We used the CRISPR/dCAS9 gene editing system to activate endogenous Nrf1 expression according to the published protocol.
28 (link) Briefly, sgRNA targeting Nrf1 was cloned into Lenti‐sgRNA (MS2)_puro (Addgene, #73795). The dCas9‐VP64 (Addgene, #61425) and MS2‐P65‐HSF1 (Addgene, #61426) were introduced simultaneously into PSCs to activate endogenous Nrf1 expression. To construct NRF1 OE plasmid, Nrf1 cDNA was amplified from mouse PSCs and cloned into SalI and NheI sites of a modified pInducer20 (p20) vector (Addgene, #44012). The correctly inserted sgRNA sequence and Nrf1 cDNA in the expression vectors were confirmed by Sanger sequencing. The sequences of sgRNA for Nrf1 activation and primers for Nrf1 cDNA cloning are listed in Table S4.
+ Open protocol
+ Expand
9

Activating Endogenous CDK13 using CRISPR-Cas9

Check if the same lab product or an alternative is used in the 5 most similar protocols
In order to activate endogenous CDK13 we used a CRISPR-Cas9 complex with three SAM components: dCas9–VP64 (Addgene #61425),MS2–p65–HSF1(Addgene, #61426), and sgRNA (Addgene, #89493) as described previously [31 (link)]. gRNAs were designed using the online optimized CRISPR design tool (http://crispr.mit.edu) and targeted the proximal promoter regions of CDK13. Oligos, synthesized by Sangon Biotech., (Shanghai, China), were annealed and sub-cloned into the lentiGuide-puro vector.
+ Open protocol
+ Expand
10

CRISPR Activation Assay using SAM System

Check if the same lab product or an alternative is used in the 5 most similar protocols
CRISPR activation assay was conducted using the SAM system (http://sam.genome-engineering.org/protocols/). The sgRNA for hLMR1 was designed using the following sequence (Forward: CACCGGACAGACAGGAGAGCAGACT, Reverse: AAACAGTCTGCTCTCCTGTCTGTCC). Briefly, the template was ligated into the sgRNA (MS2) cloning backbone (Addgene: 61424) using Golden-Gate reaction (SAM) after Golden-Gate annealing. The expression cassettes of dCas9-VP64 (Addgene: 61422) and MS2-P65-HSF1
(Addgene: 61423) were sub-cloned into pAdv5 vector (Invitrogen) for virus packaging. SgRNA elements with the U6 promoter were amplified and subsequently cloned into pAd/PL adenovirus above. Three adenoviruses (1:1:1) were delivered into humanized mice intravenously at a total of 5 × 10 8 pfu/mouse. After seven days, tissue samples were harvested for further analysis.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!